Synovial Sarcomas: Clinical Trials

4 trials for Synovial Sarcomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 4
Phase 11Recruiting 1

Follow Synovial Sarcomas: new trials by email Literature Review of Synovial Sarcomas trials Research Report on Synovial Sarcomas

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma.
Definitive radiotherapy - Soft Tissue Sarcoma (STS), Soft Tissue Sarcoma Adult
Phase 2RecruitingOslo University Hospital402026-01-262026-01-28
Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma
preoperative, Quality of life, Functional outcome - Soft Tissue Sarcoma (Excluding GIST), Soft Tissue Sarcoma Adult
Phase 2RecruitingOslo University Hospital1102026-01-262026-01-28
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
Olaparib; 177Lu-DOTATATE - Solid Tumor Cancer, Medulloblastoma
Phase 1 / Phase 2RecruitingFundación de investigación HM252024-09-202026-06-04
XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Biospecimen Collection, Computed Tomography, Echocardiography - Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma
Phase 2RecruitingNorthwestern University732024-09-192026-10-13

Narrower conditions

Sarcoma, Synovial (4)  ·  Leiomyosarcoma (3)  ·  Dermatofibrosarcoma (2)  ·  Histiocytoma, Malignant Fibrous (2)  ·  Liposarcoma (2)  ·  Osteosarcoma (2)  ·  Sarcoma (2)  ·  Adrenal Cortex Neoplasms (1)  ·  Adrenal Gland Neoplasms (1)  ·  Bone Neoplasms (1)  ·  Ependymoma (1)  ·  Esthesioneuroblastoma, Olfactory (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Medulloblastoma (1)

Broader conditions

Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Connective Tissue (4)  ·  Neoplasms, Connective and Soft Tissue (4)  ·  Neoplasms, Muscle Tissue (3)  ·  Fibrosarcoma (2)  ·  Histiocytoma (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Adipose Tissue (2)  ·  Neoplasms, Bone Tissue (2)  ·  Neoplasms, Fibrous Tissue (2)  ·  Sarcoma (2)  ·  Adrenal Cortex Diseases (1)  ·  Adrenal Gland Diseases (1)  ·  Astrocytoma (1)

Interventions

Quality of Life (1)  ·  Specimen Handling (1)  ·  lutetium Lu 177 dotatate (1)  ·  olaparib (1)

Sponsors

Oslo University Hospital (2)  ·  Fundación de investigación HM (1)  ·  Northwestern University (1)

Countries

Norway (2)  ·  Spain (1)  ·  United States (1)

Top investigators

Ivar Hompland, MD, PhD (2)  ·  Kjetil Boye, MD, PhD (2)  ·  Marta Osuna Marco, PhD (1)  ·  Pedro Hermida de Viveiros, MD (1)

NIH funding

P30CA060553 (1)